Amgen Inc (AMGN)

209.70 +0.71  +0.34% NASDAQ Oct 22, 10:15 USD
View Full Chart
Price Chart
View All AMGN News


View All Events


Date Type Description
10/28/2021 Earnings Results Q3 2021 Earnings Results
10/28/2021 14:00 EST Earnings Calls Q3 2021 Earnings Call
08/16/2021 Dividends 1.76 Normal dividend, declared July 30, 2021 and paid September 08, 2021
08/03/2021 Earnings Results Q2 2021 Earnings Results
08/03/2021 17:00 EST Earnings Calls Q2 2021 Earnings Call
05/18/2021 14:00 EST AGM 2020 Annual General Meeting
05/14/2021 Dividends 1.76 Normal dividend, declared March 03, 2021 and paid June 08, 2021
04/27/2021 Earnings Results Q1 2021 Earnings Results
04/27/2021 17:00 EST Earnings Calls Q1 2021 Earnings Call
02/11/2021 Dividends 1.76 Normal dividend, declared December 16, 2020 and paid March 08, 2021
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • Description: Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Nexavar and Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), and Lumakras (lung cancer). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
  • URL:
  • Investor Relations URL:
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Large Cap/Value
  • Next Earnings Release: Oct. 28, 2021
  • Last Earnings Release: Aug. 03, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Aug. 16, 2021

Top Fund Holders

Symbol Name Weighting
IBB iShares Biotechnology ETF 8.15%
DIA SPDR® Dow Jones Industrial Avrg ETF Tr 3.87%
SCHD Schwab US Dividend Equity ETF™ 3.69%
VPMCX Vanguard PRIMECAP Inv 3.07%
VHCOX Vanguard Capital Opportunity Inv 2.56%
XLV Health Care Select Sector SPDR® ETF 2.39%
VHCIX Vanguard Health Care Index Admiral 2.08%
VHT Vanguard Health Care ETF 2.08%
FFFMX American Funds American Mutual 529-F-3 1.99%
FWCBX American Funds Capital Income Bldr 529F3 1.45%
FLPKX Fidelity® Low-Priced Stock K 1.33%
DGRO iShares Core Dividend Growth ETF 1.17%





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.